Zobrazeno 1 - 10
of 23
pro vyhledávání: '"B J, van der Mast"'
Autor:
G.E. de Greef, B J. van der Mast, Jurjen H. L. Velthuis, Carla C. Baan, Willem Weimar, Thijs K. Hendrikx, Dennis A. Hesselink, Mariska Klepper
Publikováno v:
Transplant Immunology, 18(2), 159-165. Elsevier
Donor-specific hyporesponsiveness as occurs after allogeneic kidney transplantation may be mediated by repression of effector cells by a specific subset of T-cells: the CD4(+) CD25(bright+) FoxP3(+) regulatory T-cells (Tregs). Here, we examined the s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0ffea2f1dddeb45b7dfee770e0770356
https://pure.eur.nl/en/publications/c6d8d82e-234f-4a8c-a19e-b34ddb13b16f
https://pure.eur.nl/en/publications/c6d8d82e-234f-4a8c-a19e-b34ddb13b16f
Autor:
B J. van der Mast, J. van de Wetering, J. Rischen-Vos, P. de Kuiper, Willem Weimar, Jan N. M. IJzermans, N.M. van Besouw
Publikováno v:
Transplantation Proceedings, 37(2), 779-781. Elsevier Inc.
Background. Tapering of immunosuppressive medication is indicated to prevent long-term side effects. Recently, we have shown that renal transplant recipients can safely be converted from calcineurin inhibitors to MMF or AZA when their donor-specific
Autor:
P. J. H. Smak Gregoor, W. Weimar, J. N. M. Ijzermans, N.M. van Besouw, T. van Gelder, P. De Kuiper, Lenard M.B. Vaessen, B J. van der Mast
SUMMARY Stable cadaveric renal transplant patients were routinely converted from cyclosporin A (CsA) to either azathioprine (AZA) or mycophenolate mofetil (MMF) 1 year after transplantation to reduce the side effects of long-term immunosuppressive th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::79fab04d4adf1533e86cb86d65b9d54f
https://europepmc.org/articles/PMC1906400/
https://europepmc.org/articles/PMC1906400/
Autor:
B J, van der Mast, N M, van Besouw, P, de Kuiper, L M, Vaessen, P J, Gregoor, J N, IJzermans, T, van Gelder, F H, Claas, W, Weimar
Publikováno v:
Transplantation. 72(5)
A reliable immunological assay for quantification of donor-specific alloreactivity to identify patients at risk for future allograft rejection would be a helpful tool in organ transplantation. Therefore, we questioned whether the T cell reactivity in
Autor:
N M, van Besouw, B J, van der Mast, P, de Kuiper, P J, Smak Gregoor, L M, Vaessen, J N, IJzermans, T, van Gelder, W, Weimar
Publikováno v:
Transplantation. 70(1)
To reduce the side effects of long-term immunosuppressive therapy, stable renal transplant patients were routinely converted from cyclosporine to either azathioprine or mycophenolate mofetil. Thereafter, the azathioprine and mycophenolate mofetil dos
Autor:
P J, Smak Gregoor, T, van Gelder, N M, van Besouw, B J, van der Mast, J N, IJzermans, W, Weimar
Publikováno v:
Transplantation. 70(1)
The introduction of cyclosporine (CsA) in kidney transplantation has improved early graft survival. However, its long-term use is associated with impairment of renal function and increased cardiovascular risk factors. To avoid CsA-related long-term a
Autor:
B J, van der Mast, N M, van Besouw, P, de Kuiper, L M, Vaessen, J N, IJzermans, T, van Gelder, W, Weimar
Publikováno v:
Clinical transplantation. 14(1)
Cyclosporine (CsA) is thought to enhance transforming growth factor (TGF)-beta1 production in vitro and in vivo and this may have a negative effect on long-term graft survival. Therefore, we studied TGF-beta1, plasma levels in 30 patients before kidn
Autor:
N.M. van Besouw, T. van Gelder, W. Weimar, J. N. M. Ijzermans, P. J. H. Smak Gregoor, C. J. Hesse, B J. van der Mast
Publikováno v:
Transplant International, 13(supplement), 333-335. Wiley-Blackwell Publishing Ltd
Twenty-seven stable kidney transplant recipients treated with cyclosporine and prednisone were converted to mycophenolate mofetil (MMF) and prednisone 1 year after transplantation. After conversion the patients were treated with a standard daily dose
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::264ca01ed253950763d481a8d517dbe9
https://pure.eur.nl/en/publications/231985c9-b073-412b-aa30-8a8d63db8092
https://pure.eur.nl/en/publications/231985c9-b073-412b-aa30-8a8d63db8092
Autor:
W. Weimar, N.M. van Besouw, T. van Gelder, P. J. H. Smak Gregoor, B J. van der Mast, C. J. Hesse
Publikováno v:
Nephrology Dialysis Transplantation, 14, 706-708. Oxford University Press
Combining cyclosporin (CsA) and prednisone with mycophenolate mofetil (MMF) results in a significant reduction in the rate of biopsy-proven acute rejection after kidney transplantation. This is achieved with a standard daily MMF dosage of 2 or 3 g. W
Autor:
B J, van der Mast, A H, Balk
Publikováno v:
Transplantation. 63(10)
Pretransplant blood transfusion can have a favorable effect on renal and cardiac graft survival. In a previous study, we found that HLA-DR-shared blood transfusions led to better graft survival after kidney transplantation. In the present study, we t